Report

Diaceutics | CME confirms Diaceutics market leading position

Diaceutics held its Capital Markets Event (CME) yesterday. This was not an event that set out new targets or strategy but rather served to emphasise the leading position Diaceutics occupies in the precision medicine ecosystem and therefore confirmed its growth potential. In addition, the CME added colour to the scale of development that has taken place in the capability of the DXRX platform over the last 18 months as well as emphasising the substantial changes in organisation designed to improve the company's ability to market itself more widely and deeply across the precision medicine opportunity in pharma, biotech, and also life sciences to help find patients and thereby deliver better treatment outcomes.
Underlying
Diaceutics

Provider
Capital Access Group
Capital Access Group

Capital Access Group advises companies on effective engagement with investors. Our experienced team offers market-leading access with hard-to-reach investors, including smaller institutions, pension funds and private client fund managers. These under-serviced investors are located not only in London but across the regions of the UK and Europe. We have an unrivalled knowledge of this extensive audience, to whom our published research is distributed, as well as to larger institutions. We offer this service as part of an integrated investor communications strategy to promote a company’s investment story.

Our clients, ranging from AIM to FTSE 100 companies, benefit from our professional, long-term relationships with investors. Not only do we identify and target investors, we contact them directly and relay their views back to clients with analysis, interpretation and advice. This ensures that our clients are in control of their investor engagement. The objective is to improve the reach and engagement with investors, which in turn strengthens the share price.

Analysts
Colin Smith

Other Reports on these Companies
Other Reports from Capital Access Group

ResearchPool Subscriptions

Get the most out of your insights

Get in touch